Rubedo doses first patient in landmark trial of anti-aging drug RLS-1496
Business Wire - 22-May-2025First GPX4 modulator enters human trials to target senescent cells and combat skin aging
Join the club for FREE to access the whole archive and other member benefits.
Extending health span and reverting age-related diseases
Rubedo Life Sciences is an anti-aging company based in the Silicon Valley, California. Rubedo mission is to extend health-span by targeting cell in the body in an accurate and safe way. We aim to remove from the body "bad cells" that drive agin (such as the pro-inflammatory senescent cells), and to improve functions of "good cells (such as stem cells). Rubedo is developing treatments for aged-related diseases such as Alzheimer’s, Cancer, Diabetes, or Arthritis. The company is founded and driven by leaders in aging, regenerative medicine, senescence, combinatorial and medicinal chemistry from top academics (such as Stanford, Berkley and Cambridge UK) and top life sciences companies (such as Affymax, Xenoport, Verily).
Visit website: https://www.rubedolife.com/
Details last updated 09-Sep-2020
First GPX4 modulator enters human trials to target senescent cells and combat skin aging
A great summary of 25 speakers who are in various stages of platform building, drug discovery and clinical trials
Potentially leading to breakthroughs in managing chronic diseases
Many people believe lots of clinical trials of novel therapeutics targeting mechanisms of aging will start up in the next few years
Rubedo is planning first-in-human studies in multiple skin indications driven by chronic inflammation
Physician, scientist and biotech entrepreneur and CEO at Rubedo Life Sciences